Positives

• A long-form ME/CFS patient case account chronicled by Health Rising (the patient called Esther) describes going from severely impaired to functional after rifaximin treatment for SIBO, naming it her ME/CFS turning point Health Rising.
  
  
• After the first round of rifaximin, one ME/CFS patient reported that body pain, fatigue, malaise, and sleep all improved alongside resolution of IBS/SIBO symptoms Phoenix Rising.
  
  

Negatives

• A patient relapsed within one month and went through 4 rounds of rifaximin, with each round being progressively less potent — a common SIBO recurrence pattern Phoenix Rising.
  
  
• A patient with rifaximin-dependent gastroparesis was still taking 600 mg three times a day two years later just to maintain function, illustrating that the antibiotic can be a chronic management tool rather than a curative one Phoenix Rising.
  
  

Hurdles & Side Effects

• Brand-name Xifaxan 550 mg costs about $2,200 per month out of pocket for the standard 3x/day SIBO protocol, putting full courses out of reach for many patients without insurance authorization Phoenix Rising.
  
  
• Insurance frequently denies rifaximin for SIBO outside of IBS-D indications, forcing patients to either appeal, source generic equivalents abroad, or pursue prokinetic + diet-based maintenance regimens after each round Health Rising.